Boston, MA 03/28/2014 (medicalmarijuanareporter) – Fusion Pharm Inc. (OTCMKTS:FSPM) is another medical marijuana stock which has seen spectacular gains with the price which was at a low of $0.08 at the end of last year touching a 52-week high of $9.20 and the present price is $5.12. It manufactures a commercial cultivation technology called PharmPods (patent pending) which is an advanced hydroponic method in which standard steel shipping containers are used in indoor controlled environments. The technology also allows users greater control over what a plant receives avoiding the use of herbicides and pesticides and producing an increased yield.
Plants can be grown in a variety of media using nutrient solutions which contain a concentrated form of the minerals the plants would receive if they were grown on soil. The media provide more oxygen which stimulates the growth of the roots. The energy the plants do not have to use in searching for nutrients can be used for faster growth and a better yield. As a result, leafy vegetables like lettuce which require up to 65 days to mature outdoors lucky patcher download no root can be produced indoors in 24 days. The company has announced that revenues grew by 38% quarter on quarter for the quarter ended 30 September 2013.
Fusion Pharm Inc. (OTCMKTS:FSPM) is now set to ship its second Canadian order and the initial order worth $270,000 is the first of an anticipated $2.3 million. The Canadian market has become the largest customer base. The company has leased space in Seattle and expects to open a design and sales center for Washington State later this year. It expects to follow suit in every one of its major markets. Earlier, in February 2014, it completed a round of equity funding worth $1 million with the funds earmarked for ongoing operations such as expanded manufacturing and the establishment of new sales center. If you believe in the future of vertical farming and cannabis cultivation and have the appetite for risk, you can consider an investment.